Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAP: Testosterone Pretreatment in Poor Responders with Androgen Receptor Polymorphism Undergoing ICSI
2024-510596-37-00Phase 4Withdrawn
- Sponsor
- Instituto Bernabeu
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of AndroForte in Diminished Ovarian Reserve (DOR) and female infertility (2 arms), sponsored by Instituto Bernabeu. Primary endpoint: number of oocyte cumulus complexes obtained. Planned start Apr 2024; status: withdrawn.
02
Drugs
AndroForte
03
Conditions
Diminished Ovarian Reserve (DOR)female infertility
Beyond the preview
Go deeper on 2024-510596-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510596-37-00.